Bernd Clement

This inventor holds 17 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Christian-Albrechts-Universitaet Zu Kiel, Christian-Albrechts-Universitat Zu Kiel, Dritte Patentportfolio Beteiligungsgesellschaft Mbh &Co. Kg. Active years: 1998-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Clement. Retrieved from https://idiyas.com/inventor/bernd-clement

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 8)

% Patents Active = 52.9

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 37(Granted Patents)

Location History:

24106 Kiel, DE (2004)
Kiel, DE (1998 - 2021)

Company Filing History:

3 out of 26

Christian-Albrechts-Universitaet Zu Kiel

patents

3 out of 19

Christian-Albrechts-Universitat Zu Kiel

patents

3 out of 13

Dritte Patentportfolio Beteiligungsgesellschaft Mbh &Co. Kg

Christian-Albrechts-University of Kiel

patent

6. 1 out of 1

Dritte Patentportfolio Beteiligungsgesellschaft Mgh & Co. Kg

8. 3 out of 834,601

Other

patents

Years Active: 1998-2021

Loading Chart...

Areas of Expertise:

Pyrido-Phenanthroline

Pentamidine Prodrugs

Antibacterial Compounds

Influenza Treatment

Dimethylarginine Inhibitors

Phenanthridine Derivatives

Amino Acid Derivatives

Urokinase Inhibitors

NO-Synthase Inhibitors

Biphenylyl Compounds

Pharmaceutical Preparations

Cancer Treatment

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11046693 - Pyrido-phenanthroline derivatives, production and use thereof as medicaments (2021-06-29),

2. 9828333 - Compounds for the treatment of influenza (2017-11-28),

3. 9693974 - Antibacterial and antifungal biphenylyl compounds (2017-07-04),

4. 9662308 - Orally bioavailable pentamidine prodrugs for the treatment of diseases (2017-05-30),

5. 9387185 - [object Object] (2016-07-12),

6. 9353047 - Method for producing prodrug from amidoxime and N-hydroxyguanidine carboxylic acid esters (2016-05-31),

7. 9062054 - Pyrido [3,4-C] [1,9] phenanthroline and 11, 12 dihydropyrido [3,4-C] [1,9] phenanthroline derivatives and the use thereof, particularly for treating cancer (2015-06-23),

8. 8921421 - Inhibitors of dimethylarginine dimethylaminohydrolase (2014-12-30),

9. 8853245 - Orally bioavailable dabigatran prodrugs for the treatment of diseases (2014-10-07),

10. 8658826 - Amino acid derivatives used as pharmaceutical substances (2014-02-25),

11. 7994365 - Basic acetophenones as inhibitors of NO-synthases (2011-08-09),

12. 7807681 - Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors (2010-10-05),

13. 7608623 - Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors (2009-10-27),

14. 7320980 - Substituted pyrido(1,2-a)pyrimidines and their use as NOS inhibitors (2008-01-22),

15. 6747038 - Phenanthridine derivatives and antitumoral medicaments containing phenanthridine (2004-06-08),

Title: Bernd Clement: Innovator from Kiel, DE

Introduction: Bernd Clement is a renowned inventor hailing from Kiel, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Bernd Clement holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials.

Career Highlights: Throughout his career, Bernd Clement has worked with leading research institutions and universities to develop cutting-edge technologies that have had a significant impact on the industry.

Collaborations: Bernd Clement has collaborated with top companies in the automotive and energy sectors to bring his inventions to the market, showcasing his ability to bridge the gap between academia and industry.

Conclusion: Bernd Clement's passion for innovation and his dedication to creating a sustainable future make him a key figure in the world of inventors and innovators.

Profile summary based on public USPTO records.